285313
Comparison of influenza vaccination among clinical and nonclinical health care personnel (HCP), United States, early 2012-13 influenza season
Gary Euler, MPH, DrPH
,
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA
Jun Zhang, MD, MSPH
,
National Center for Immunizationa and Respiratory Diseases, SAIC & Centers for Disease Control and Prevention, Atlanta, GA
Samuel Graitcer, MD
,
Centers for Disease Control and Prevention, Atlanta, GA
Marie de Perio, MD
,
Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, OH
David Izrael, MS
,
US Health Division, Abt Associates, Inc., Cambridge, MA
Sarah W. Ball, MPH, ScD
,
US Health Division, Abt Associates, Inc., Cambridge, MA
Deborah Klein Walker, EdD
,
US Health Division, Abt Associates, Inc., Cambridge, MA
Rachel Martonik
,
Abt SRBI, Silver Spring, MD
Stacie Greby, DVM, MPH
,
National Center for Immunization and Respiratory Diseases, Centers for Disease Control & Prevention, Atlanta, GA
Background: HCP vaccination can reduce influenza complications among themselves, family members, co-workers, and patients. Despite recommendations for annual HCP influenza vaccination, coverage remains below 70%, with clinical HCP coverage higher than nonclinical HCP coverage although both are at risk. We examined HCP employment characteristics to understand factors associated with vaccination. Methods: Data from a November 2012 national internet-panel survey of HCP were used to assess self-reported vaccination status and employment characteristics. Nonclinical HCP reported working as administrative staff, managers, or support staff (e.g., housekeeping). The sample was weighted to reflect the U.S. HCP population. Of HCP starting the survey, 1,976 were eligible for analysis (95%). We compared clinical (n=1,534) and nonclinical (n=442) HCP using weighted analyses. Results: Coverage was higher among clinical vs. nonclinical HCP (65.7% vs. 54.7%). Compared to clinical HCP, nonclinical HCP were less likely to work in hospitals (39.3% vs. 33.9%) and report employer vaccination requirements (23.6% vs. 18.7%). The majority of HCP with employer requirements worked in hospitals. In hospital settings with employer requirements, vaccination coverage among clinical HCP was 92.4% vs. 76.9% among nonclinical HCP peers. In non-hospital settings without employer requirements, vaccination coverage among clinical HCP was 47.7% vs. 42.6% among nonclinical HCP peers. Conclusions: While employer requirements were associated with higher vaccination among clinical and nonclinical HCP, requirements alone did not ensure all HCP were vaccinated. Barriers to vaccination should be assessed and addressed as part of a comprehensive HCP immunization strategy, particularly among nonclinical HCP and in non-hospital settings without employer requirements.
Learning Areas:
Administer health education strategies, interventions and programs
Occupational health and safety
Protection of the public in relation to communicable diseases including prevention or control
Public health or related organizational policy, standards, or other guidelines
Learning Objectives:
Compare influenza vaccination coverage levels among clinical and nonclinical health care personnel.
Identify demographic and occupational characteristics of clinical and nonclinical health care personnel among whom influenza vaccination is most common.
Describe employer influenza vaccination requirements among clinical and nonclinical health care personnel.
Keywords: Health Care Workers, Immunizations
Presenting author's disclosure statement:Qualified on the content I am responsible for because: I participated in the analysis and interpretation of the data. I am a researcher and evaluator at Abt Associates, and direct or participate in a number of public health studies.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.